United States · FDA National Drug Code directory
Aripiprazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 46708-254_5108607e-5633-4b19-82f9-6c48720960c4
- Product NDC
- 46708-254
- Form
- TABLET
- Composition / generic term
- Aripiprazole
- Labeler
- Alembic Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150428
- Source listing expiry
- 20261231
Source-listed ingredients
- ARIPIPRAZOLE — 2 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 CARTON (46708-254-10) · 46708-254-10
- 30 TABLET in 1 BOTTLE (46708-254-30) · 46708-254-30
- 100 TABLET in 1 BOTTLE (46708-254-31) · 46708-254-31
- 180 TABLET in 1 BOTTLE (46708-254-45) · 46708-254-45
- 60 TABLET in 1 BOTTLE (46708-254-60) · 46708-254-60
- 500 TABLET in 1 BOTTLE (46708-254-71) · 46708-254-71
- 1000 TABLET in 1 BOTTLE (46708-254-91) · 46708-254-91
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →